Portfolio - Diagnostics

Contact:

Jennifer McMahon

Biosensia

Biosensia Limited is an in vitro diagnostic company that has developed the RapiPlex, an innovative and proprietary immunoassay technology platform.  The RapiPlex enables rapid, reliable and highly sensitive tests to be performed outside of the central lab.  As a point of care platform, it is suitable for deployment in a wide range of settings with a broad range of clinical diagnostic applications.  The RapiPlex has multiplexing capability and can be used on a variety of samples including whole blood, serum, plasma, urine and saliva.

< back to portfolio